BreathePub Date : 2026-01-27eCollection Date: 2026-01-01DOI: 10.1183/20734735.0254-2025
Rannvá Winther, Søren Sperling, Andreas Fløe
{"title":"Treatment strategies for <i>Mycobacterium avium</i> pulmonary disease.","authors":"Rannvá Winther, Søren Sperling, Andreas Fløe","doi":"10.1183/20734735.0254-2025","DOIUrl":"https://doi.org/10.1183/20734735.0254-2025","url":null,"abstract":"<p><p>Macrolides are known to play a key role in the treatment of nontuberculous mycobacteria. However, the optimal combination and number of drugs remains uncertain. Nagawawa <i>et al.</i> and Zweijpfenning <i>et al.</i> investigated these questions in two randomised controlled trials exploring treatment regimens for <i>Mycobacterium avium</i> complex (MAC) infections, while Nguyen <i>et al</i>. summarised some of these questions in a meta-analysis. Nagawawa <i>et al.</i> compared an intermittent three-drug regimen to daily therapy, while Zweijpfenning <i>et al.</i> compared rifampicin or clofazimine as adjuncts to ethambutol and a macrolide. Tolerance levels for intermittent therapy were not significantly superior to those of daily therapy, while a clofazimine-ethambutol-macrolide regimen was non-inferior to one including rifampicin. Finally, Nguyen <i>et al</i>. conclude that a two-drug regimen may be a viable option for treating MAC infections.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 1","pages":"250254"},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BreathePub Date : 2026-01-27eCollection Date: 2026-01-01DOI: 10.1183/20734735.0005-2025
Mathieu Marillier, Athénaïs Boucly, Matteo Siciliano, Marjolein A Heuvelmans, Amanda Dandanell Juul, Chiara Premuda, Susanne J H Vijverberg, Heleen Demeyer, Laura Fabbri, Augusta Beech, Thomas Gille, Sara Cuevas Ocaña
{"title":"Work-life balance as early career respiratory experts and ERS representatives: personal experiences, reflections and potential solutions for improvement.","authors":"Mathieu Marillier, Athénaïs Boucly, Matteo Siciliano, Marjolein A Heuvelmans, Amanda Dandanell Juul, Chiara Premuda, Susanne J H Vijverberg, Heleen Demeyer, Laura Fabbri, Augusta Beech, Thomas Gille, Sara Cuevas Ocaña","doi":"10.1183/20734735.0005-2025","DOIUrl":"https://doi.org/10.1183/20734735.0005-2025","url":null,"abstract":"<p><p>Work-life balance is a real challenge for early career respiratory professionals striving to manage clinical responsibilities, research, teaching and professional commitments. In this collective reflection by members of the European Respiratory Society Early Career Member Committee, we openly explore our own experiences, struggles and lessons learned in the pursuit of balance. While some of us feel we have found a rhythm that works, many are still navigating fluctuating demands, blurred boundaries and long hours that spill into evenings, weekends and even holidays. Parenthood, changing roles and growing responsibilities have reshaped our priorities and tested our limits. Still, we remain deeply passionate about our work. Through honest discussion, we share personal strategies such as setting boundaries, using time-management tools and leaning on support networks, and highlight the emotional toll when the balance is lost. We also recognise that systemic change is needed: fairer compensation, cultural shifts around overwork, and structural support for young professionals. This article is both a reflection and a call to action: to take care of ourselves, to support one another and to shape a professional culture where wellbeing is valued as much as productivity. We hope our shared experiences resonate and offer encouragement to other early career respiratory professionals.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 1","pages":"250005"},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BreathePub Date : 2026-01-27eCollection Date: 2026-01-01DOI: 10.1183/20734735.0243-2025
Yasmeen Al-Hindawi, Onno W Akkerman, Anthony Byrne, Raquel Duarte, Ernesto Jaramillo, Olha Konstantynovska, Chiara Premuda, Cristina Vilaplana, Giovanni Battista Migliori, Gunar Günther, Kerri Viney, Dennis Falzon
{"title":"Post-tuberculosis lung disease.","authors":"Yasmeen Al-Hindawi, Onno W Akkerman, Anthony Byrne, Raquel Duarte, Ernesto Jaramillo, Olha Konstantynovska, Chiara Premuda, Cristina Vilaplana, Giovanni Battista Migliori, Gunar Günther, Kerri Viney, Dennis Falzon","doi":"10.1183/20734735.0243-2025","DOIUrl":"https://doi.org/10.1183/20734735.0243-2025","url":null,"abstract":"<p><p>Tuberculosis (TB) burden concentrates in low-income settings and remains the leading global cause of death from a single infectious agent, despite that it is preventable and treatable. TB-associated lung diseases (TBALD), a broad range of respiratory abnormalities which can start before or during a TB episode, may increase morbidity. TBALD may persist after successful completion of TB treatment as post-TB lung disease (PTLD). PTLD varies in severity and is characterised by persistent respiratory symptoms and lung impairment that can significantly impact social activities, health-related quality of life, and long-term survival. Risk factors for PTLD include increasing age, smoking, HIV infection, delayed diagnosis, and poor socioeconomic conditions. Action to limit PTLD may be taken before TB develops through TB screening, early diagnosis and TB preventive treatment, during treatment of TB, and upon its completion. Early detection, clinical assessment, and tailored management (including smoking cessation, immunisation, addressing respiratory comorbidities, pulmonary rehabilitation and social protection) can mitigate impairment and disability. Healthcare providers and national programmes play a vital role through clinical follow-up, patient education, and integration of TBALD care into broader health and social protection services. Sustained funding and research are crucial for this and to develop new tools to enhance care.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 1","pages":"250243"},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BreathePub Date : 2026-01-27eCollection Date: 2026-01-01DOI: 10.1183/20734735.0058-2025
Chiara Premuda, Martina Santambrogio, Sofia Misuraca, Gianmarco Putti, Filippo Maraz, Andrea Sarassi, Anna Bulfamante, Francesco Blasi, Andrea Gramegna
{"title":"Nonpharmacological interventions for managing infections in chronic respiratory diseases: a comprehensive overview.","authors":"Chiara Premuda, Martina Santambrogio, Sofia Misuraca, Gianmarco Putti, Filippo Maraz, Andrea Sarassi, Anna Bulfamante, Francesco Blasi, Andrea Gramegna","doi":"10.1183/20734735.0058-2025","DOIUrl":"https://doi.org/10.1183/20734735.0058-2025","url":null,"abstract":"<p><p>Respiratory tract infections are common within the general population and present a significant burden on healthcare systems, particularly in people with predisposing conditions such as chronic respiratory diseases. While pharmacological interventions remain a cornerstone of treatment, nonpharmacological strategies play a complementary role in both management and prevention of these conditions. These approaches encompass a broad range of measures, including adequate nutrition and hydration, preventive practices, stress reduction, and respiratory physiotherapy. This review aims at providing a comprehensive overview of these non-strictly pharmacological strategies of support and prevention to be adopted in the care of patients with respiratory conditions.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 1","pages":"250058"},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Secondary infections following tuberculosis: epidemiology, pathogenesis and clinical implications.","authors":"Mariona Cortacans, Nino Gogichadze, Pablo Soldevilla, Zoran Stojanovic, Onno Akkerman, Raquel Duarte, Cristina Vilaplana","doi":"10.1183/20734735.0055-2025","DOIUrl":"https://doi.org/10.1183/20734735.0055-2025","url":null,"abstract":"<p><p>This review brings together global data on bacterial, fungal, nontuberculous mycobacterial (NTM) and viral infections that complicate the course of individuals following the diagnosis of pulmonary or extrapulmonary tuberculosis (TB). It shows how residual structural lung damage (bronchiectasis, cavitation, residual fibrotic lesions) and persistent immune dysregulation create niches for pathogens, most notably <i>Pseudomonas aeruginosa</i>, <i>Aspergillus</i> spp., <i>Mycobacterium avium</i> complex and herpes zoster virus. Although bacterial infections in post-TB bronchiectasis are the most consistently documented, chronic pulmonary aspergillosis and NTM disease add substantial morbidity. Viral complications beyond herpes zoster and influenza remain poorly characterised, underscoring a critical evidence gap. In extrapulmonary TB survivors, organ-specific sequelae pose additional infection risks that are rarely quantified. Across all categories, inconsistent case definitions, under-utilisation of the 10th revision of the International Classification of Diseases coding, and lack of prospective cohorts have obscured the true burden of post-TB infections. The review concludes by calling for standardised diagnostic criteria, enhanced epidemiological tracking, and integrated post-treatment care pathways including preventive vaccinations to mitigate long-term health consequences in this vulnerable population.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 1","pages":"250055"},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BreathePub Date : 2026-01-27eCollection Date: 2026-01-01DOI: 10.1183/20734735.0228-2025
Zainab Afzal, David Quigley, John Hogan, Fiona Murphy, Reza Ghasemi
{"title":"When tuberculosis turns critical: a rare constellation of severe complications.","authors":"Zainab Afzal, David Quigley, John Hogan, Fiona Murphy, Reza Ghasemi","doi":"10.1183/20734735.0228-2025","DOIUrl":"https://doi.org/10.1183/20734735.0228-2025","url":null,"abstract":"<p><p><b>TB is a complex multifaceted disease with varying presentations and complications. Antimicrobial treatment remains the mainstay of treatment of trachea-oesophageal fistula secondary to TB; however, invasive interventions can be considered for complex cases.</b> https://bit.ly/4qvsMct.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"22 1","pages":"250228"},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839465/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BreathePub Date : 2025-12-16eCollection Date: 2025-10-01DOI: 10.1183/20734735.0266-2025
Radu Marian Gheorghiu, Alexandra Tița
{"title":"Ethical, gamified spirometry for preschoolers: a step-by-step protocol for reliable lung-function data.","authors":"Radu Marian Gheorghiu, Alexandra Tița","doi":"10.1183/20734735.0266-2025","DOIUrl":"10.1183/20734735.0266-2025","url":null,"abstract":"<p><p><b>Preschool spirometry thrives on empathy: greet at eye level, link devices to familiar cues, gamify each blow, and coach with a gentle rise-fall voice. This playful standards-based script boosts success and slashes distress, preserving autonomy for all.</b> https://bit.ly/4nGTOvs.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"21 4","pages":"250266"},"PeriodicalIF":3.4,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12706589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145773723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BreathePub Date : 2025-12-16eCollection Date: 2025-10-01DOI: 10.1183/20734735.0282-2025
Guido Marchi
{"title":"Exploring pleural effusion characterisation with quantitative thoracic ultrasound imaging: a viewpoint on the investigational role of pixel-based echogenicity analysis in transudate and exudate differentiation.","authors":"Guido Marchi","doi":"10.1183/20734735.0282-2025","DOIUrl":"10.1183/20734735.0282-2025","url":null,"abstract":"<p><p>Pleural effusion represents a frequent and diagnostically challenging condition across multiple clinical settings. Conventional characterisation relies on invasive thoracentesis and biochemical analysis, with Light's criteria offering high sensitivity but limited specificity. Procedural risks and patient factors may limit fluid sampling, highlighting the need for complementary, noninvasive approaches. Recent advances in thoracic ultrasound (TUS) suggest that quantitative assessment of pleural fluid (PF) echogenicity, particularly pixel density analysis and hypoechogenicity index, may represent an investigational approach for objective and reproducible evaluation. Preliminary studies using standardised image analysis platforms, such as ImageJ, indicate that exudative effusions more frequently exhibit higher pixel density than transudates, in association with markers of cellularity, protein content, and inflammation. Hybrid scoring systems combining quantitative metrics with morphological sonographic features, such as septations, fibrin strands, and debris, have been explored and may enhance diagnostic specificity, although validation remains limited. However, methodological constraints, operator- and device-dependent variability and small sample sizes continue to restrict their applicability in routine clinical practice. Emerging approaches, including artificial intelligence, may be able to mitigate these limitations by standardising measurements, harmonising grayscale output, and integrating clinical, laboratory and imaging data to generate real-time risk scores. In the absence of robustly validated evidence, quantitative TUS should be regarded as an investigational adjunct, with potential to refine PF characterisation, support clinical decision-making, and inform future research on noninvasive diagnostic strategies.</p>","PeriodicalId":9292,"journal":{"name":"Breathe","volume":"21 4","pages":"250282"},"PeriodicalIF":3.4,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12706588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145773681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}